Detalles de la búsqueda
1.
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID Study.
Clin Gastroenterol Hepatol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729389
2.
Long-term risk of delayed postoperative Crohn's disease recurrence in patients with no or mild endoscopic recurrence at first assessment.
Eur J Clin Invest
; : e14219, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38647188
3.
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity.
Gut
; 72(3): 443-450, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36008101
4.
Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 21(5): 1354-1355.e2, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35307594
5.
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial.
Clin Gastroenterol Hepatol
; 20(9): 2074-2082, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34843987
6.
Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study.
Clin Gastroenterol Hepatol
; 20(4): 787-797.e2, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33359726
7.
Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID.
Am J Gastroenterol
; 117(9): 1482-1490, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973142
8.
IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers.
Rheumatology (Oxford)
; 61(5): 1957-1965, 2022 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34427590
9.
How are patients' preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn's disease patients.
Scand J Gastroenterol
; 57(11): 1312-1320, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722732
10.
Predictors of each quality of life dimension in Crohn's disease patients initiating an anti-TNF treatment: differentiated effects of patient-, disease-, and treatment-related characteristics.
Scand J Gastroenterol
; 57(5): 566-573, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35188859
11.
Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study.
Scand J Gastroenterol
; 57(12): 1454-1462, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35819361
12.
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
BMC Gastroenterol
; 22(1): 498, 2022 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36457080
13.
Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study.
Dig Dis Sci
; 67(12): 5637-5646, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35384624
14.
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
Dig Dis Sci
; 67(9): 4525-4532, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35246801
15.
Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies.
Clin Gastroenterol Hepatol
; 19(4): 713-720.e1, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32272248
16.
Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease.
Clin Gastroenterol Hepatol
; 19(5): 947-954.e2, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360982
17.
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine.
Clin Gastroenterol Hepatol
; 19(6): 1180-1188.e4, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32777552
18.
Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
Gastroenterology
; 158(3): 515-526.e10, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31711925
19.
Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.
Gastroenterology
; 159(1): 139-147, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32224129
20.
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.
Am J Gastroenterol
; 116(1): 134-141, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33177349